Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the β-catenin pathway

Molecular and Cellular Biology

Volumn 21, Issue 17, 2001, Pages 5857-5868

  Danilkovitch Miagkova, A ^a   Miagkov, A ^a   Skeel, A ^a   Nakaigawa, N ^a   Zbar, B ^a   Leonard, E J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; BETA CATENIN; CYCLIN D1; MET RECEPTOR TYROSINE KINASE; MUTANT PROTEIN; MYC PROTEIN; PROTEIN TYROSINE KINASE; RON RECEPTOR TYROSINE KINASE; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; BETA CATENIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; CYTOSKELETAL PROTEINS; DOGS; GLYCOGEN SYNTHASE KINASE 3; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEINS; PROTO-ONCOGENE PROTEINS C-MET; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TYROSINE;

ANIMALIA;

EID: 0034908762     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.17.5857-5868.2001     Document Type: Article

References (119)

1. Beta-catenin is a target for the ubiquitin-proteasome pathway
2. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation
3. Modulation of megakaryocytopoiesis by human macrophage-stimulating protein, the ligand for the RON receptor
4. Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth
5. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta
6. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene
7. Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer
8. APC: The plot thickens
9. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene
10. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogen product
11. Regulation, substrates and functions of src
12. The role of beta-catenin in cell adhesion, signal transduction, and cancer
13. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
14. A common human skin tumour is caused by activating mutations in beta-catenin
15. Expression of c-Myc in response to colony-stimulating factor-1 requires mitogen-activated protein kinase kinase-1
16. Axin and hepatocellular carcinomas
17. Molecular cloning of a new transforming gene from a chemically transformed human cell line
18. Structure and functions of the 20S and 26S proteasomes
19. Tyrosine phosphorylation and cadherin/catenin function
20. Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells
21. Kinases involved in MSP/RON signaling
22. Integrin-mediated RON growth factor receptor phosphorylation requires tyrosine kinase activity of both the receptor and c-Src
23. Expression of the Met/HGF receptor in normal and neoplastic human tissues
24. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas
25. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer
26. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling
27. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons
28. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit
29. Cross-talk between the proto-oncogenes MET and RON
30. Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors
31. RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP
32. Hepatocyte growth factor-scatter factor: Mitogen, motogen, and met
33. The c-met/HGF receptor in human tumours
34. Tyrosine kinase receptor indistinguishable from the c-met protein
35. Scatter factor induces blood vessel formation in vivo
36. p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system
37. Identification of c-MYC as a target of the APC pathway
38. A simplified system for generating recombinant adenoviruses
39. Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells
40. Hepatocyte growth factor/scatter factor disrupts epithelial tumour cell-cell adhesion: Involvement of beta-catenin
41. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
42. The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor
43. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with axin
44. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin
45. PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin
46. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha
47. Terminal differentiation of murine resident peritoneal macrophages is characterized by expression of the STK protein tyrosine kinase, a receptor for macrophage-stimulating protein
48. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family
49. Dual regulation of proliferation and apoptosis: C-myc in bitransgenic murine mammary tumor models
50. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis
51. Activating mutations for the met tyrosine kinase receptor in human cancer
52. The mutationally activated MET receptor mediates motility and metastasis
53. Peroxide(s) of vanadium: A novel and potent insulin-mimetic agent which activates the insulin receptor kinase
54. c-erbB-2 gene product directly associates with beta-catenin and plakoglobin
55. Regulation of beta-catenin signaling in the Wnt pathway
56. Modulation of Wnt signaling by axin and axil
57. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma
58. Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: The emerging role of p27(kip) in malignant transformation of neurofibromas
59. Macrophage-stimulating protein activates STK receptor tyrosine kinase on osteoclasts and facilitates bone resorption by osteoclast-like cells
60. Beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression
61. Overexpression of the RON gene in human breast carcinoma
62. Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development
63. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts
64. Liver regeneration: Molecular mechanisms of growth control
65. Characterization of two monoclonal antibodies against the RON-tyrosine kinase receptor
66. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor
67. Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases
68. Beta-catenin signaling and cancer
69. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
70. Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration
71. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
72. Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src
73. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures
74. Hepatocyte growth factor as a hematopoietic regulator
75. Wnt genes
76. Beta-catenin is a major tyrosine-phosphorylated protein during mouse oocyte maturation and preimplantation development
77. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species
78. The multiple endocrine neoplasia type 2B point mutation alters long-term regulation and enhances the transforming capacity of the epidermal growth factor receptor
79. Regulation of complexed and free catenin pools by distinct mechanisms. Differential effects of Wnt-1 and v-Src
80. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells
81. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors
82. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus
83. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase
84. The oncogenic activation of beta-catenin
85. Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide)
86. Conditional transformation of rat embryo fibroblast cells by a cyclin Dl-cdk4 fusion gene
87. p120, a novel substrate of protein tyrosine kinase receptors and of p60v-src, is related to cadherin-binding factors beta-catenin, plakoglobin and armadillo
88. Activation of the JNK pathway is essential for transformation by the Met oncogene
89. A novel putative receptor protein tyrosine kinase of the met family
90. Regulation of E-cadherin/Catenin association by tyrosine phosphorylation
91. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor
92. Stabilization of beta-catenin by genetic defects in melanoma cell lines
93. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B
94. Constitutive activation of the RON gene promotes invasive growth but not transformation
95. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor
96. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
97. Scatter factor/hepatocyte growth factor is essential for liver development
98. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
99. Novel mutations of the MET proto-oncogene in papillary renal carcinomas
100. Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells
101. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway
102. Drosophila wingless: A paradigm for the function and mechanism of Wnt signaling
103. Site-specific tyrosine phosphorylation of IkappaBalpha negatively regulates its inducible phosphorylation and degradation
104. The v-sea oncogene of avian erythroblastosis retrovirus S13: Another member of the protein-tyrosine kinase gene family
105. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
106. An epithelial scatter factor released by embryo fibroblasts
107. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate
108. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
109. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin
110. Role of c-kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cells
111. Specific proto-oncogenic tyrosine kinases of src family are enriched in cell-to-cell adherens junctions where the level of tyrosine phosphorylation is elevated
112. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells
113. Macrophage-stimulating protein induces proliferation and migration of murine keratinocytes
114. Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein
115. Identification of the ron gene product as the receptor for the human macrophage stimulating protein
116. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex
117. METprc mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acqisition of oncogenic potential
118. Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability
119. Wnt-1 induces growth, cytosolic β-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts